Hospital
Southern Tennessee Medical Center LLC
Southern Tennessee Medical Center LLC was paid $9.39M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is 99284, emergency room visit (serious) — 46% of everything it billed.
33Billing provider infoSOUTHERN TENNESSEE MEDICAL CENTER LLC
WINCHESTER, TN 37398
WINCHESTER, TN 37398
33aNPI1467408781assigned 05/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.39M
24GClaims200,933
24DCodes billed106
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#28 of 71
Median peer was paid$6.96M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,646 | $1.47M | |
| 2019 | 23,607 | $1.31M | |
| 2020 | 22,319 | $979K | |
| 2021 | 32,761 | $1.34M | |
| 2022 | 37,906 | $1.58M | |
| 2023 | 40,407 | $1.55M | |
| 2024incomplete | 21,287 | $1.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 46% | 29,789 | 25,792 | $4.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 24,947 | 22,152 | $3.06M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.3% | 6,872 | 2,893 | $311K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.0% | 1,285 | 1,106 | $285K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 4,703 | 4,011 | $209K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.9% | 1,244 | 984 | $178K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 4,688 | 4,220 | $162K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 3,612 | 3,291 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 25,099 | 20,508 | $106K |
| 80053 | Comprehensive metabolic panel | <1% | 22,244 | 18,360 | $70K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,833 | 4,276 | $47K |
| 97597 | <1% | 2,520 | 1,203 | $42K |
94 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,847 | $42K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,240 | $37K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 713 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,860 | $34K |
| 84484 | <1% | 3,856 | $34K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,860 | $19K |
| 83735 | <1% | 5,369 | $18K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,815 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 897 | $17K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 16 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,017 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,564 | $15K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 527 | $14K |
| 64493 | <1% | 60 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,023 | $12K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 534 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,710 | $10K |
| 87430 | <1% | 1,055 | $9K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 69 | $8K |
| 83690 | <1% | 1,822 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 74 | $7K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 177 | $7K |
| 83605 | <1% | 1,055 | $7K | |
| 87070 | <1% | 921 | $6K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 229 | $6K |
| 93017 | <1% | 113 | $6K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 15 | $5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 123 | $5K |
| 87486 | <1% | 108 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 108 | $5K |
| 81001 | <1% | 6,218 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 768 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,432 | $4K |
| 81025 | <1% | 1,244 | $4K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 39 | $4K |
| 82150 | <1% | 984 | $4K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 31 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 565 | $3K |
| 83880 | <1% | 581 | $3K | |
| 64494 | <1% | 59 | $3K | |
| 78414 | <1% | 70 | $3K | |
| 85730 | <1% | 1,121 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 39 | $3K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 70 | $3K |
| 93226 | <1% | 41 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 859 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 17 | $2K |
| 82550 | <1% | 646 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 45 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 284 | $2K |
| 85610 | <1% | 1,189 | $2K | |
| 86141 | <1% | 465 | $2K | |
| 87581 | <1% | 43 | $2K | |
| 81003 | <1% | 2,033 | $1K | |
| 87634 | <1% | 39 | $1K | |
| 11045 | <1% | 63 | $1K | |
| 93225 | <1% | 118 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 616 | $1K |
| 76801 | <1% | 17 | $1K | |
| 80061 | Lipid panel | <1% | 170 | $886.02 |
| 74018 | <1% | 35 | $714.97 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 46 | $604.17 |
| 94060 | <1% | 14 | $536.64 | |
| 87400 | <1% | 106 | $519.11 | |
| 84100 | <1% | 304 | $375.73 | |
| 87799 | <1% | 14 | $365.86 | |
| 82247 | <1% | 67 | $338.36 | |
| 87040 | <1% | 43 | $282.77 | |
| 82570 | <1% | 95 | $280.06 | |
| 94727 | <1% | 14 | $258.64 | |
| 94729 | <1% | 14 | $221.49 | |
| 85378 | <1% | 17 | $146.45 | |
| 83970 | <1% | 43 | $145.20 | |
| 80305 | <1% | 32 | $118.37 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 75 | $116.72 |
| 87205 | <1% | 51 | $64.14 | |
| 88304 | <1% | 46 | $43.27 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 306 | $38.83 |
| 72110 | <1% | 18 | $33.59 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 861 | $30.26 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,065 | $19.86 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,297 | $2.24 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,783 | $1.32 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 402 | $1.26 |
| 85651 | 0% | 29 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 456 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 13 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 26 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 32 | $0.00 |
| 84134 | 0% | 28 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 15 | $0.00 |
| 87077 | 0% | 44 | $0.00 | |
| 87075 | 0% | 51 | $0.00 | |
| 87186 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.